Welzel, T. M., Nelson, D. R., Morelli, G., Di Bisceglie, A., Reddy, R. K., Kuo, A., . . . Zeuzem, S. (2017). Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: Results of the real-world, clinical practice HCV-TARGET study. Gut.
Citação norma ChicagoWelzel, Tania M., et al. "Effectiveness and Safety of Sofosbuvir Plus Ribavirin for the Treatment of HCV Genotype 2 Infection: Results of the Real-world, Clinical Practice HCV-TARGET Study." Gut 2017.
Deismireacht MLAWelzel, Tania M., et al. "Effectiveness and Safety of Sofosbuvir Plus Ribavirin for the Treatment of HCV Genotype 2 Infection: Results of the Real-world, Clinical Practice HCV-TARGET Study." Gut 2017.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.